Abstract:
The present disclosure relates to a collection of novel muteins derived from human α1m (or a1m) polypeptide or a functional homologue thereof. The disclosure further refers to a α1m mutein capable of specifically binding to one or more targets other than a target to which wild-type α1m binds. The disclosure also relates to a method for producing such collection of muteins and a method for isolating a mutein capable of binding one or more such non-natural targets of wild-type α1m polypeptide. These aspects are made possible due to, e.g, the structural elucidation of α1m disclosed herein by the present inventors, an appreciation of ligand-binding sights thereof and, hence, an understanding of which amino acid positions are most suitable for mutagenesis for re-engineering specificity and affinity for any given target while maintaining the secondary and/or tertiary structure of a1m.
Abstract:
The present invention is directed to a method of producing spider dragline and/or flagelliform proteins. The invention is further directed to a method of producing spider threads and to a dragline/flagelliform protein or dragline/flagelliform protein thread produced by these methods. The invention further provides the use of these proteins/threads in the field of biotechnology and/or medicine, in particular in the manufacture of wound closure or coverage systems, suture materials and in the manufacture of replacement materials, preferably artificial cartilage or tendon materials.
Abstract:
The present invention relates to a method for preparation of a functionalized surface comprising the steps: a) coating of a carrier with a least one polymer selected from a polyanionic or polycationic polymer, b) addition of at least one compound to the coated carrier of step a), c) exposing the at least one polyanionic or polycationic polymer on the coated carrier of step b) to an organic solvent, resulting in compaction of the at least one polyanionic or polycationic polymer and thereby encapsulating the at least one compound, d) reversible cross-linking of the at least one polyanionic or polycationic polymer of step c) with at least one cross-linker; e) removal of the organic solvent. Furthermore, the invention relates to a functionalized surface, a functionalized surface for use in medicine and a method for releasing a compound ex vivo.
Abstract:
The present invention relates to a rechargeable electrochemical cell comprising at least one cathode (A) comprising at least one electroactive sulfur-containing material, at least one anode (B), and at least one electrolyte composition (C) comprising at least one aprotic organic solvent (c1), at least one alkali metal salt (c2), and at least one redox mediator (c3). The present invention further relates to an alkali metal ion battery comprising at least one re- chargeable electrochemical cell as described above and to a device comprising at least one rechargeable electrochemical cell as described above. The present invention further relates to a process for charging for the first time a newly manufactured rechargeable electrochemical cell initially comprising at least one cathode (A) comprising at least one electroactive sulfur- containing material comprising at least one Li-S-group, at least one anode (B), and at least one electrolyte composition (C) comprising at least one aprotic organic solvent (c1), at least one alkali metal salt (c2), and at least one redox mediator (c3).
Abstract:
The present invention relates to rechargeable electrochemical cells comprising (A) at least one cathode comprising (A1 ) at least one cathode active material comprising (a) at least one graphitized carbon black and (aa) at least one binder, and optionally at least one solid material through which gas can diffuse or which optionally serves as a carrier for the cathode active material, and B) at least one anode comprising metallic magnesium, metallic aluminum, metallic zinc, metallic sodium or metallic lithium. The present invention further relates to the use of inventive electrochemical cells and to metal-air batteries comprising the latter.
Abstract:
The present invention is directed to a yeast cell for producing a recombinant collagen like protein. The present invention is further directed to a kit of parts or a co-expression system for use in the production of such a protein and to a method of producing said recombinant protein and a thread made therefrom. Furthermore, the invention pertains to proteins or threads obtainable by these methods as well as their use in various fields of technology and medicine.
Abstract:
The present invention is directed to interaction partners of ALK fusion proteins and to nucleic acids encoding same. It is further directed to nucleic acids, which selectively hybridize to transcriptional products of those nucleic acids as well as to a molecule, which specifically binds to an interaction partner of this invention. The invention is further related to compositions containing the aforementioned ingredients as well as to their use in the diagnosis and therapy of cancer, degenerative and proliferative disorders.
Abstract:
A method for a neural network comprising an input layer, an output layer and one or more intermediate layers is described. The neural network is arranged to generate an output vector of data values at the output layer corresponding to a learned representation of an input vector of data values that is input to the neural network. The method comprises accessing a set of data variables that are determined according to respective entries of output vectors, the output vectors generated on the basis of the evaluation of the neural network on input vectors of data values selected from a training dataset of input vectors, evaluating a predictive model over the set of data variables to determine a subset of data variables and modifying the predictive model and the neural network on the basis of the evaluation whereby the evaluation of the subset of data variables for subsequent input vectors of data values that are input to the neural network generate output vectors of data values that are grouped, according to a measure of similarity, into at least two substantially disjoint subsets.
Abstract:
Network management apparatus and methods are described. A network management apparatus comprises network data receiving means for receiving network data that is representative of the current condition of a communications network, the network data comprising a plurality of values indicative of the performance of network elements; network data transformation means for transforming the received network data into a network state vector that is indicative of a current state of the network; and network state prediction means for predicting a future network state vector of the network from the current network state vector, the network state prediction means comprising a self- learning prediction module having a memory for storing at least one internal state.
Abstract:
The present invention relates to a peptide comprising a reversible affinity tag (A); and a functionalization tag (F), wherein the peptide is linked to a target of interest (T). The peptide is useful as a versatile protein tag. The invention further provides structures comprising the peptide, nucleic acids, vectors, and host cells. Further, the invention provides methods of producing or using the peptide.